---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-014372"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-02T23:55:54.956059+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Vascular Q1 sales $53.5M (+14%), EPS $0.44 (+62%); raises FY op. margin guidance to 22%

## Summary
- Q1 net income $9.9M (+64%); gross margin 68.6% (+300 bps) on price increases and manufacturing efficiencies.
- Allografts (+31%), carotid shunts (+27%), and APAC sales (+44%) led growth; organic sales +11%.
- Board declared $0.16/share dividend payable May 30 to holders of record May 16.
- FY 2024 guided sales $212.7-217.3M (+11%), EPS $1.73-1.84 (+33% vs. FY 2023), operating margin 22%.
- Share repurchase program of up to $50M authorized through Feb 2025.

## SEC filing metadata
- accession: 0001437749-24-014372
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000143774924014372/0001437749-24-014372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000143774924014372/lmat20240502_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-014372
- JSON: https://secwatch.observer/filing/0001437749-24-014372.json
- Plain text: https://secwatch.observer/filing/0001437749-24-014372.txt

## Key facts
- Earnings Releases
  LEMAITRE VASCULAR INC reported the quarter ended March 31, 2024 results: revenue $53.5mm, net income $9.9mm, EPS $0.44. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2024
  - Revenue: $53.5mm
  - Net income: $9.9mm
  - EPS: $0.44
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q1 2024 Financial Results ● Sales $53.5mm, +14% (+11% organic) vs. Q1 2023 ● Gross margin 68.6%, +300 bps ● Op. income $11.9mm, +51% ● Op. margin 22% ● Net income $9.9mm, +64% ● Earnings per diluted share $0.44, +62%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1158895/000143774924014372/0001437749-24-014372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.